Literature DB >> 8973430

Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.

J Eskola1, R M Olander, T Hovi, L Litmanen, S Peltola, H Käyhty.   

Abstract

BACKGROUND: Inclusion of new vaccines in vaccination programmes for children would be easier if they could be combined with existing vaccines. Vaccines containing acellular pertussis in the diphtheria/tetanus/pertussis (DTP-a) combination are expected to replace the conventional whole-cell vaccines (DTP-w). We tested the immunogenicity and safety of a combination of DTP-a with the Haemophilus influenzae type b (Hib) conjugate of Hib capsular polysaccharide and tetanus toxid (PRP-T), and inactivated poliovirus vaccine (i.p.v.).
METHODS: 120 infants were enrolled and randomised to four groups to receive DTP-a at ages 2, 4, and 6 months. At 4 and 6 months they also received Hib conjugate and i.p.v., either as separate injections or mixed with DTP-a. All injections were given intramuscularly in the anterolateral area of the thigh. Any reactions after each vaccination were noted by the parents. EIA was used to measure titres of diphtheria, tetanus, and pertussis antibodies, RIA for Hib anticapsular antibodies, and microneutralisation assay for poliovirus antibodies from serum samples collected at the ages of 2, 4, 6, and 7 months.
FINDINGS: There were 30 infants in each group. Only mild adverse events were reported. There was a tendency towards slightly lower concentrations of filamentous haemagglutinin, tetanus, and poliovirus 1 antibodies when the vaccines were mixed. However, there was a more pronounced difference (p = 4 x 10(-6)) in Hib antibodies between groups receiving Hib capsular polysaccharide mixed with DTP-a (geometric mean concentrations 0.37 microgram/mL and 0.56 microgram/mL) compared with groups receiving the vaccines separately (3.10 micrograms/mL and 3.94 micrograms/mL).
INTERPRETATION: Administration of premixed DTP-a, Hib conjugate, and i.p.v. affect the immune response significantly. The mechanism of this interference is not clear. The immunogenicity of all antigens must be tested before new combinations can be accepted for vaccination programmes for infants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973430     DOI: 10.1016/S0140-6736(96)04356-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  H. influenzae type b (Hib) vaccine--controversies.

Authors:  Nitin K Shah
Journal:  Indian J Pediatr       Date:  2003-06       Impact factor: 1.967

Review 2.  Conjugate vaccines.

Authors:  A Finn; P Heath
Journal:  Arch Dis Child       Date:  2005-07       Impact factor: 3.791

3.  Evaluation of combinatorial vaccines against anthrax and plague in a murine model.

Authors:  Amanda B DuBois; Lucy C Freytag; John D Clements
Journal:  Vaccine       Date:  2007-04-20       Impact factor: 3.641

Review 4.  Childhood immunisation today.

Authors:  J Eskola
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

5.  Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.

Authors:  M Kauppi-Korkeila; L Saarinen; J Eskola; H Käyhty
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

6.  DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation.

Authors:  M H Slack; S Cade; D Schapira; R J Thwaites; A Crowley-Luke; J Southern; R Borrow; E Miller
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

Review 7.  Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters.

Authors:  P C Humphryes; M E Weeks; M AbuOun; G Thomson; A Núñez; N G Coldham
Journal:  Clin Vaccine Immunol       Date:  2014-02-12

Review 9.  DTaP-IPV/Hib vaccine (Pentacel).

Authors:  Sohita Dhillon; Susan J Keam
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age.

Authors:  Ronald Gold; Luis Barreto; Santiago Ferro; John Thippawong; Roland Guasparini; William Meekison; Margaret Russell; Elaine Mills; Dana Harrison; Pierre Lavigne
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.